Drugs

Page 26 of 28

The 10 Biggest Health Care Companies in the Fortune 500
Features

The 10 Biggest Health Care Companies in the Fortune 500

By
June 20, 2015
JAPAN-US-TOYOTA-CRIME-MANAGEMENT

Julie Hamp’s drug arrest puts Toyota in damage control mode

By
June 19, 2015
The Colorado Supreme Court listens to arguments in the the case of Brandon Coats, a quadriplegic medical marijuana patient who was fired from his job at Dish Network after testing positive for marijuana. A written decision by the court will be issued at a
Careers

You can still get fired in this state for using medical marijuana

By
June 15, 2015
Ross William Ulbricht
Tech

The Silk Road mastermind appealed his life sentence

By
June 5, 2015
Silk Road mastermind pleads for light sentence
Retail

Silk Road mastermind pleads for light sentence

By
May 27, 2015
Biopharma deals are booming this year with no end in sight
Finance

Biopharma deals are booming this year with no end in sight

By
May 8, 2015
J&J brings in ethicists to judge on requests for experimental drugs
Features

J&J brings in ethicists to judge on requests for experimental drugs

By
May 7, 2015
Inside of a Gilead Sciences Lab
Tech

Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal

By
May 6, 2015
PA: Mylan Headquarters
Finance

Mylan goes big with $29 billion offer to buy Perrigo

By
April 8, 2015
States ask U.S. Congress to launch inquiry of herbal supplements
Retail

States ask U.S. Congress to launch inquiry of herbal supplements

By
April 2, 2015
IL: Corporations In Illinois
International

Takeda’s ready to shell out $2.2 billion to settle Actos drug cases

By
April 1, 2015
Where do CEOs with addictions go when they hit bottom?
Leadership

Where do CEOs with addictions go when they hit bottom?

By
March 25, 2015
Merck
Features

Merck halts study in light of melanoma drug’s success

By
March 24, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Features

How Biogen scored the most successful Alzheimer’s drug so far

By
March 21, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

Valeant comes out a winner after upping its Salix bid to $11.1 billion

By
March 16, 2015

Most Popular